Table of Contents
Hepatitis Research and Treatment
Volume 2014, Article ID 307942, 7 pages
http://dx.doi.org/10.1155/2014/307942
Research Article

Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia

1Department of Pediatric Hepatology, National Liver Institute, Menofiya University, Shebin El-koom, Menofiya 32511, Egypt
2Department of Microbiology and Immunology, National Liver Institute, Menofiya University, Shebin El-koom, Menofiya 32511, Egypt
3Department of Pediatrics, Faculty of Medicine, Menofiya University, Shebin El-koom, Menofiya 32511, Egypt

Received 5 June 2014; Revised 2 September 2014; Accepted 3 September 2014; Published 14 September 2014

Academic Editor: Piero Luigi Almasio

Copyright © 2014 Mostafa M. Sira et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Mostafa M. Sira, Behairy E. Behairy, Azza M. Abd-Elaziz, Sameh A. Abd Elnaby, and Ehab E. Eltahan, “Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia,” Hepatitis Research and Treatment, vol. 2014, Article ID 307942, 7 pages, 2014. https://doi.org/10.1155/2014/307942.